Product logins

Find logins to all Clarivate products below.


Enterprise Solutions | Market Insights | US | 2023

The COVID-19 global pandemic has had a negative impact on the US market for enterprise solutions, resulting in declines in unit sales and revenue in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the increasing movement toward value-based healthcare and effective population health management in the US, as well as continued hospital consolidation, although market saturation, healthcare system budgetary constraints, and competition from enterprise solutions will limit the pace of market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for enterprise solutions in the US from 2019 through 2031.

Related Medtech Insights Reports

Report
Enterprise Solutions – Market Insights – United States
Although the US enterprise solution market was negatively impacted during the height of the COVID-19 global pandemic, the market continues to recover and will ultimately see robust growth through…
Report
Enterprise Solutions – Market Insights – Europe
The COVID-19 pandemic has had a negative impact on the European enterprise solution market. However, following a period of recovery, the market will grow strongly through 2032, driven by the…
Report
Peripheral Vascular Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness…
Report
Trauma Devices | Market Insights | US | 2023
Given the urgent nature of the procedures within the trauma device market, the impact of the COVID-19 pandemic was less severe and the recovery was relatively fast for the US trauma device…
Report
Dialysis Access Treatment Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European dialysis access treatment device market in 2020, and to some extent in 2021. Once the market stabilizes, the European dialysis access…